Table 2 |
|
|
Logistic regression of component factors in cardiovascular disease risk, adjusted for age and gender. |
|
|
CVD complication |
B exponential = Odds Ratio(95%CI)* |
|
|
|
|
All complications |
Females;OR = 2.26(1.48–3.47) |
|
Metabolic syndrome (WHO criteria);OR = 3.48(2.26–5.37) |
|
|
Metabolic syndrome (IDF criteria);OR = 2.28(1.84–4.90) |
|
|
Coronary |
Metabolic syndrome (WHO criteria);OR = 3.10(1.48–6.49) |
|
Metabolic syndrome (IDF criteria);OR = 1.96(1.15–4.89) |
|
|
Cerebrovascular |
Females;OR = 2.46(1.06–5.37) |
|
Metabolic syndrome (NCEP criteria);OR = 2.59(1.26–5.27) |
|
|
Peripheral vascular |
Females; OR = 3.61(1.72–7.55) |
|
Metabolic syndrome (WHO criteria);OR = 2.26(1.11–4.61) |
|
|
Metabolic syndrome (NCEP criteria);OR = 2.74(1.82–5.33) |
|
|
Retinopathy |
Metabolic syndrome (NCEP criteria);OR = 2.80(1.07–7.34) |
|
Metabolic syndrome (IDF criteria);OR = 3.63(2.27–7.94) |
|
|
Nephropathy |
Females; OR = 2.97(1.32–6.66) |
|
Metabolic syndrome (WHO criteria); OR = 11.78(4.91–28.3) |
|
|
Metabolic syndrome (IDF criteria);OR = 3.51(2.07–12.2) |
|
|
Neuropathy |
Metabolic syndrome (NCEP criteria);OR = 12.41(1.44–106.9) |
|
|
|
|
* For each component are indicated those components included in the regression equation. The rest of the components did not reach statistical significance and, as such, have not been included in the table |
|
|
Cabré et al. BMC Public Health 2008 8:251 doi:10.1186/1471-2458-8-251 |
|